IntelliCell BioSciences, Inc. (OTC: SVFC) is a regenerative medicine company utilizing adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. IntelliCell Biosciences has developed its own patented technology and protocol to separate … Continue reading →

Skkynet Cloud Systems, Inc. (OTCBB: SKKY), through wholly owned subsidiary Cogent Real-Time Systems Inc., has developed DataHub® software and related systems and facilities for over-network collecting, processing, and distributing real-time information to remotely manage, supervise and control industrial processes, embedded devices and financial information … Continue reading →

TapImmune, Inc. (OTCQB: TPIV) is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The company’s vaccine compositions, peptide or nucleic acid-based, comprise one or multiple naturally processed epitopes (NPEs) … Continue reading →

Heat Biologics, Inc. (NASDAQ: HTBX) is a clinical-stage biopharmaceutical company developing novel ImPACT therapeutic vaccines to treat a wide range of cancers.  ImPACTTherapy is designed to deliver live, genetically modified, irradiated human cells reprogrammed to “pump out” cancer-associated antigens. The technology is … Continue reading →

Targeted Medical Pharma, Inc. (OTCQB: TRGM) is a biotechnology company that develops prescription medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company manufactures 10 proprietary prescription-only medical foods, … Continue reading →

Direct Insite Corp. (OTCBB: DIRI) provides cloud-based e-invoicing solutions for accounts payable, accounts receivable and payments automation. The company’s services are currently used by more than 450,000 suppliers and customers in more than 100. Direct Insite’s Invoices On-Line™ platform provides … Continue reading →

MYOS Corp. (OTCQB: MYOS) is a development stage company engaged in the discovery, development and commercialization of products that improve muscle health and function essential to the management of sarcopenia (age-related loss of muscle mass), cachexia (general physical wasting and … Continue reading →

Blue Calypso (OTCBB: BCYP) develops digital innovation products and services for the social media marketplace using its patented IP portfolio. The company enables businesses to use digital advertising to share and socialize brand content as well as track performance, monitor … Continue reading →

Solar Wind Energy Tower, Inc. (OTCQB: SWET) and its wholly owned commercializing subsidiary Solar Wind Energy, Inc. are the inventors of the patented Solar Wind Downdraft Tower, which produces continuous , inexpensive electricity. Solar Wind Energy is also focused on … Continue reading →

Protea Biosciences Group, Inc. (OTCBB: PRGB) is a commercial-stage molecular information company providing innovative technologies, software and services to the pharmaceutical, biotechnology, agriculture, chemical and other industries. Its proprietary technology, LAESI®, is able to detect the presence of molecules from … Continue reading →